How do we manage vaccinations in patients with inflammatory bowel disease?

Digestive Diseases

Volumn 27, Issue 3, 2009, Pages 370-374

  Esteve Comas, Maria ^a   Loras Alastruey, Carme ^a   Fernandez Bañares, Fernando ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Immunosuppression; Inflammatory bowel disease; Opportunistic infections; Vaccination

Indexed keywords

AZATHIOPRINE; CHICKENPOX VACCINE; CHOLERA VACCINE; CORTICOSTEROID; DIPHTHERIA VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLIXIMAB; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; MERCAPTOPURINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; TETANUS TOXOID; TICK BORNE ENCEPHALITIS VACCINE; TYPHOID VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

CHICKENPOX; CHOLERA; CONFERENCE PAPER; CROHN DISEASE; DIPHTHERIA; ENTERITIS; EPIDEMIC ENCEPHALITIS; HEPATITIS A; HEPATITIS B; HUMAN; INFLUENZA; MEASLES; MENINGOCOCCOSIS; MUMPS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PRIORITY JOURNAL; RABIES; RHEUMATIC DISEASE; RUBELLA; TETANUS; TICK BORNE ENCEPHALITIS; TYPHOID FEVER; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; VACCINATION; YELLOW FEVER;

ADULT; CHILD; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; HEALTH PLANNING GUIDELINES; HUMANS; IMMUNITY; INFLAMMATORY BOWEL DISEASES; VACCINATION;

EID: 70349901337     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228576     Document Type: Conference Paper

References (13)

1. Hutfless SM, Weng X, Liu L, Allison J, Herrinton LJ: Mortality by medication use among patients with inflammatory bowel disease, 1996-2003. Gastroenterology 2007; 133: 1779-1786.
2. Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF: Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut 2008; 57: 549-558.
3. Garcia-Vidal C, Rodríguez-Fernández S, Teijón S, Esteve M, Rodríguez-Carballeira M, Lacasa JM, Salvador G, Garau J: Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention. Eur J Clin Microbiol Infect Dis 2009; 28: 331-337.
4. Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ: Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008; 134: 929-936.
5. Bernstein CN, Rawsthorne P, Blanchard JF: Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 759-762. (Pubitemid 46909992)
6. Loras C, Saro C, Gonzalez-Huix F, Mínguez M, Merino O, Gisbert JP, Barrio J, Bernal A, Gutiérrez A, Piqueras M, Calvet X, Andreu M, Abad A, Ginard D, Bujanda L, Panés J, Torres M, Fernández-Bañares F, Viver JM, Esteve M; REPENTINA study, Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa: Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol 2009; 104: 57-63.
7. Melmed GY, Ippoliti AF, Papadakis KA, Tran TT, Birt JL, Lee SK, Frenck RW, Targan SR, Vasiliauskas EA: Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 2006; 101: 1834-1840. (Pubitemid 44166594)
8. Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN: Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5: 851-856. (Pubitemid 47031059)
9. Lu Y, Jacobson DL, Ashworth LA, Grand RJ, Meyer AL, McNeal MM, Gregas MC, Burchett SK, Bousvaros A: Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol 2009; 104: 444-453.
10. Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, Rimmelzwaan GF, Kroon FP: The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 2008; 67: 713-716.
11. Melmed GY, Frenck R, Barolet-Garcia C, Ibanez P, Simpson P, Papadakis KA, Ward J, Ippoliti A, Targan SR, Vasiliauskas EA: TNF blockers and immunomodulators impair antibody response to pneumococcal polysaccharide vaccine (PPV) in patients with inflammatory bowel disease. Gastroenterology 2008; 134:A68.
12. Vida Pérez L, Gómez Camacho F, García Sánchez V, Iglesias Flores EM, Castillo Molina L, Cerezo Ruiz A, Casáis Juanena L, De Dios Vega JF: Adequate rate of response to hepatitis B virus vaccination in patients with inflammatory bowel disease. Med Clin (Barc) 2009; 132: 331-335.
13. Sands BE, Cuffari C, Katz J, Kugathasan S, Onken J, Vitek C, Orenstein W: Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 677-692. (Pubitemid 39276481)